Dr. Mehrnaz N. Jamali, MD

Dr. Jamali practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Jamali's NPI, 1346273406, was assigned on July 9, 2006. Dr. Jamali graduated from McGovern Medical School in 1993. Dr. Jamali holds California license A53933.

Dr. Jamali's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Jamali's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Jamali is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Jamali to 5 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamali practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Jamali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Jamali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Jamali's licenses on file in 2 states: California and Texas.

Dmand AI lists acute diabetes, acute respiratory failure, bile duct problems, cardiac arrhythmia, cellulitis, collapsed lung, congestive heart failure and electrolyte disorders among the conditions Dr. Jamali treats.

CMS data shows 268 Medicare services from Dr. Jamali across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $28,443 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Jamali in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have heart failure, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jamali's median patient age at 68, with 45% women.

In 2024, Dr. Jamali wrote 286 Medicare Part D claims for 84 patients. 82% of them were for generic drugs. CMS names the drug for 94 of them, across 7 drugs with 11 or more claims each, at $8,091 in total drug cost. In 2023, CMS named 276 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Jamali for performance year 2024, reported as part of a group. Dr. Jamali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 65 general payments to Dr. Jamali from 8 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $489.

Dr. Jamali graduated from McGovern Medical School in 1993.

Dr. Jamali is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.